2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400901 ↗At a glance
Journal article in ChemMedChem, 2025. Written by Zheng Ma and 4 co-authors. Institution: State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic C…. Major MEDLINE topics: Boronic Acids, Klebsiella pneumoniae, Anti-Bacterial Agents, beta-Lactamase Inhibitors. Cited 2 times so far (Crossref); 36 references. Funded by: NSFC-BRICS, Fundamental Research Funds for the Central Universities, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism.
Abstract (original language)
The expression of Klebsiella pneumoniae carbapenemase (KPC), a type of carbapenem‐hydrolyzing β‐lactamase, in Gram‐negative bacteria has caused significant bacterial resistance to carbapenems, the antibiotic of last resort. Herein, we describe the discovery of 2‐carboxyquinoline boronic acids as inhibitor of KPC. We have identified fluoro‐substituted carboxyquinoline boronic acids 1 e as the most potent inhibitor, with an IC 50 of 8.3 nM for KPC‐2, while this compound is significantly less efficient at reducing the activity of other β‐lactamases. This compound proved to have low cytotoxicity towards mammalian cells, as well as low haemolysis and antibacterial activity. However, 1 e potentiated the efficacy of β‐lactam antibiotics (e. g., meropenem and ceftazidime) against KPC‐2‐expressing resistant Klebsiella pneumonia by up to 256‐fold.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techn…
ORCID profiles: Hexin Xie
Funding
- NSFC-BRICS
- Fundamental Research Funds for the Central Universities
- Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism
- Shanghai Municipal Education Commission
- Research Program of State Key Laboratory of Bioreactor Engineering
Cite
APA
Ma, Z., Cui, G., Dou, L., Chen, F., & Xie, H. (2025). 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202400901
Vancouver
Ma Z, Cui G, Dou L, Chen F, Xie H. 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. 2025. doi:10.1002/cmdc.202400901
BibTeX
@article{Ma2025,
author = {Ma, Zheng and Cui, Ge and Dou, Lijie and Chen, Fangfang and Xie, Hexin},
title = {2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400901}
}
EUVIMED